Start of program: 2011
COUNTRY KEY FIGURES
- 13.13 million inhabitants¹
- 30,770 COVID-19 cases²
ALIMA KEY FIGURES
- 2,330 patients monitored as part of the PREVAC-UP
- 4,399 suspected and confirmed COVID-19 patients cared for
Areas of intervention
- Research and Innovation
- Outbreak Response
- Maternal health
In Guinea, maternal and infant mortality is still very high. Moreover, the Guinean health system was particularly affected by the Ebola epidemic in 2015³.
Much of the Guinean population has inadequate access to medical facilities. The country’s health system has been further strained by various outbreaks, including the COVID-19 pandemic.
ALIMA’s Impact – Our fieldwork
Implementation of research projects against Ebola
Two research projects continued this year:
- The PREVAC (Partnership for Research on Ebola Vaccination) phase II trial, which started in 2015, to identify an effective Ebola vaccine. In 2020, over 2,300 enrolled participants continued to be monitored, as part of a longer-term study, called PREVAC-UP.
- The Ebovac III project, a trial that aims to evaluate the efficacy of an Ebola vaccine in infants younger than one year.
Implementation of the AIRE (Improving the Identification of Respiratory Distress in Children) Project
The implementation of the AIRE (Improving the Identification of Respiratory Distress in Children) project, which is funded by Unitaid, began in 2020. The AIRE teams collected information and established partnerships that are essential to the continuation of the project over the next few years.
The project also adapted to the pandemic with “COVID-AIRE,” enabling the implementation of 30 patient triage circuits, the donation of 30 IPC triage kits, 34 pulse oximeters and 10 oxygen concentrators.
© Sylvain Cherkaoui / Cosmos for ALIMA
Focus on 2020
In 2020, ALIMA monitored 2,330 individuals in the PREVAC-UP project and provided care to 4,339 patients with COVID-19.
To support the Guinean Ministry of Health’s response to the COVID-19 epidemic, ALIMA supported the Donka University Hospital in Conakry. Our teams set up a 450-bed treatment facility, including a triage area and laboratory, as well as a 40-bed Intensive Care Unit (ICU). Over 3,800 confirmed patients received medical care, including 416 in the ICU. More than 98% of COVID-19 patients that ALIMA cared for recovered. Our teams also trained over 150 people in the medical and psychological care of patients who have tested positive and reinforced Infection Prevention and Control (IPC) measures.
* Cover picture © Jennifer Lazuta / ALIMA
¹ World Bank (2020)
² Our World in Data (2021)
³ Unicef 2020